COSCIENS Biopharma Inc.

CSCI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$16,393$6,678$10,176$6,103
Short-Term Investments$0$0$0$0
Receivables$2,471$290$2,126$1,677
Inventory$2,691$4,009$2,768$73
Other Curr. Assets$2,426$290$100$150
Total Curr. Assets$23,981$11,267$15,170$9,731
Property Plant & Equip (Net)$10,966$11,645$11,938$13,725
Goodwill$0$0$0$0
Intangibles$0$7$9$12
Long-Term Investments$0$0$0$335
Tax Assets$0$75$0$222
Other NC Assets$123$751$687$664
Total NC Assets$11,089$12,478$12,634$14,623
Other Assets$0$0$0$0
Total Assets$35,070$23,745$27,803$24,353
Liabilities
Payables$2,407$0$0$0
Short-Term Debt$271$596$387$357
Tax Payable$130$0$0$0
Deferred Revenue$120$0$2,948$4,808
Other Curr. Liab.$4,294$727$1,674$1,130
Total Curr. Liab.$7,222$1,311$7,041$7,755
LT Debt$2,039$1,399$65$1,850
Deferred Rev, NC$914$0$1,683$1,491
Deferred Tax Liab, NC$0$0$808$0
Other NC Liab.$11,734$0$0$17,802
Total NC Liab.$14,687$1,399$2,464$19,324
Other Liabilities$0$0$0$0
Cap. Leases$2,310$1,698$338$2,078
Total Liabilities$21,909$2,710$4,012$2,612
Equity
Pref Stock$0$0$0$0
Common Stock$22,486$13,517$12,301$12,986
Retained Earnings-$12,110$4,356$8,017$5,084
AOCI-$1,483$0$4,116$4,401
Other Equity$4,268$3,162$3,474$3,671
Total Equity$13,161$21,035$23,791$21,741
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$35,070$23,745$27,803$24,353
Net Debt-$14,083-$4,683-$9,724-$3,895
COSCIENS Biopharma Inc. (CSCI) Financial Statements & Key Stats | AlphaPilot